文献速递白血病

PAX5双等位基因变异定义新型B细胞前体急性淋巴细胞白血病亚组

PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2019-03-06

该研究分析250例B细胞前体急性淋巴细胞白血病(BCP-ALL)病例,通过DNA甲基化和基因表达谱鉴定出19例「PAX5-plus」新亚组,所有患者均携带PAX5双等位基因突变(热点p.P80R),常伴CDKN2A/B纯合缺失和RAS激活突变,成人患者中12例有10例获长期生存,但样本量有限仅见更优临床结局趋势。

要点

  • PAX5-plus亚组以PAX5双等位基因突变(热点p.P80R)为特征,占250例BCP-ALL中的19例。
  • 该亚组富集CDKN2A/B纯合缺失和RAS激活热点突变,形成独特的三重变异模式。
  • 成人PAX5-plus患者12例中10例获长期生存,但样本量有限,仅见更优结局趋势。

核心结论

  • PAX5-plus是首个由序列变异而非大体染色体事件定义的BCP-ALL亚组,展示分化失调(PAX5)、细胞周期调控受损(CDKN2A/B)和持续增殖信号(RAS)协同驱动白血病发生。

研究设计与样本

  • 研究分析了250例B细胞前体急性淋巴细胞白血病(BCP-ALL)病例,通过DNA甲基化和基因表达谱鉴定亚组。
  • PAX5-plus亚组共19例,涵盖儿童和成人患者。

主要发现

  • 所有PAX5-plus患者均携带PAX5突变,热点为p.P80R,突变或影响两个独立密码子(复合杂合)或通过9p染色体异常发生LOH。
  • 双等位基因事件破坏调控B细胞分化和抑癌功能的PAX5转录程序。
  • CDKN2A/B纯合缺失和RAS激活热点突变在该亚组基因组中高度富集,形成该亚组独有的三重变异模式。
  • 成人PAX5-plus患者12例中10例获长期生存,但受样本量限制仅见更优临床结局趋势。

关键数值与推荐

  • PAX5-plus亚组定义为具有独特DNA甲基化和基因表达谱且携带PAX5双等位基因突变的病例(n=19)。
  • PAX5突变热点为p.P80R。
  • 成人PAX5-plus患者12例中10例获长期生存。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 样本量有限,仅观察到更优临床结局的趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chromosomal rearrangements and specific aneuploidy patterns are initiating events and define subgroups in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here we analyzed 250 BCP-ALL cases and identified a novel subgroup ('PAX5-plus', n = 19) by distinct DNA methylation and gene expression profiles. All patients in this subgroup harbored mutations in the B-lineage transcription factor PAX5, with p.P80R as hotspot. Mutations either affected two independent codons, consistent with compound heterozygosity, or suffered LOH predominantly through chromosome 9p aberrations. These biallelic events resulted in disruption of PAX5 transcriptional programs regulating B-cell differentiation and tumor suppressor functions. Homozygous CDKN2A/B deletions and RAS-activating hotspot mutations were highly enriched as cooperating events in the genomic profile of PAX5-plus ALL. Together, this defined a specific pattern of triple alterations, exclusive to the novel subgroup. PAX5-plus ALL was observed in pediatric and adult patients. Although restricted by the limited sample size, a tendency for more favorable clinical outcome was observed, with 10 of 12 adult PAX5-plus patients achieving long-term survival. PAX5-plus represents the first BCP-ALL subgroup defined by sequence alterations in contrast to gross chromosomal events and exemplifies how deregulated differentiation (PAX5), impaired cell cycle control (CDKN2A/B) and sustained proliferative signaling (RAS) cooperatively drive leukemogenesis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Bastian L, Schroeder MP, Eckert C, et al. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia. Leukemia. 2019. PMID: 30842609. doi:10.1038/s41375-019-0430-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。